| Financial Year |
March 31 2023 |
| Monetary Funds |
144,465,897.70 |
| Held-for-trading Financial Assets |
55,000,000.00 |
| Notes Receivable |
6,274,555.99 |
| Accounts Receivable |
288,030,776.01 |
| Advances to Suppliers |
9,217,064.96 |
| Other Receivables |
6,616,207.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
273,940,647.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
852,090.80 |
| Other Current Assets |
13,280,665.81 |
| Total Current Assets |
841,615,410.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
281,917,335.50 |
| Under-construction Projects |
152,604,245.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
114,540,683.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
347,093.12 |
| Deferred Income Tax Assets |
20,467,551.02 |
| Other Non-Current Assets |
56,823,370.58 |
| Sub-Total of Non-Current Assets |
627,763,742.38 |
| Total Assets |
1,469,379,153.22 |
| Short-Term Loans |
176,221,591.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
179,092,677.60 |
| Accounts Payable |
44,640,396.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,727,650.39 |
| Taxes Payable |
3,079,132.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,071,183.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
268,191.06 |
| Other Current Liabilities |
1,258,939.63 |
| Sub-Total of Current Liabilities |
425,899,096.29 |
| Long-term Loans |
25,026,877.78 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,635,737.78 |
| Deferred Income Tax Liabilities |
8,193,238.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
64,372,033.00 |
| Total Liabilities |
490,271,129.29 |
| Paid-In Capital(Or Share Stock) |
170,670,000.00 |
| Capital Surplus |
583,750,593.98 |
| Surplus Reserve |
39,866,654.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
175,622,896.53 |
| Minority Stockholder's Interest |
8,734,805.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
970,373,218.74 |
| Owner's Equity（Stockholder's Equity） |
979,108,023.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,469,379,153.22 |
